CNR2 and thyroid tumor: The administration of CB2 agonist JWH133 (daily intratumoral injection of 50 μg/mL for 3 weeks) led to a considerable regression of thyroid tumors generated in nude mice by inoculation of the TC cells ARO/CB2 [106].